[144] CALIX, INC SEC Filing

Rhea-AI Filing Summary

Form 144 notice: A holder plans to sell up to 24,000 shares of the issuer’s common stock with an aggregate market value of $1,539,240. The intended sales are through Morgan Stanley Smith Barney LLC, with an approximate sale date of 11/10/2025 on the NYSE.

The 24,000 shares were acquired on 11/10/2025 via a stock option exercise from the issuer for cash. Shares outstanding were 66,276,473. The filer also reported a prior sale of 50,000 shares on 11/04/2025 for gross proceeds of $3,266,850.

Insights

Capital markets counsel

Administrative resale filing; neutral impact.

This is a Rule 144 notice of a proposed sale of restricted/controlled stock. It lists a planned sale of 24,000 common shares with an aggregate market value of $1,539,240, to be executed via Morgan Stanley Smith Barney LLC on or about 11/10/2025 on the NYSE.

The shares to be sold were acquired the same day via a stock option exercise for cash. The excerpt also notes a prior sale of 50,000 shares on 11/04/2025 with gross proceeds of $3,266,850. Shares outstanding are stated as 66,276,473; this is a baseline figure. Overall, this filing permits potential sales under Rule 144; actual market impact depends on execution.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	24000	1539240.00	66276473	11/10/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/10/2025	Stock Option Exercise	Issuer			24000	11/10/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Shane Eleniak 3155 Olsen Drive, Suite 450 SAN JOSE CA 95117	Common	11/04/2025	50000	3266850.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)